GFR PHARMACEUTICALS INC
CIK 0001096294
Revenue (TTM)
—
Q1 May 2013
Net Income (TTM)
$1.32M
−35.2% YoY
Q1 May 2013
EPS Diluted (TTM)
—
Q1 May 2013
Gross Margin
—
Q1 May 2013
Operating Margin
—
Q1 May 2013
Net Margin
—
Q1 May 2013
Free Cash Flow (TTM)
$1.19M
Q1 May 2013
Cash
$1.05M
Q1 May 2013
Total Debt
—
Q1 May 2013
Shares Outstanding
42.08M sh
Q1 May 2013
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.